This is Archived Content

This content is available for historical purposes only. It may not reflect the current state of science or language from the National Institute on Drug Abuse (NIDA). Find the latest information on substance use, health, and NIDA research at

Cite this article

NIDA. (2017, April 17). Dr. Rita Valentino to lead NIDA’s neuroscience and behavior division. Retrieved from

press ctrl+c to copy

Brings expertise in neurobiological foundation of substance use behaviors

April 17, 2017

Dr. Rita ValentinoDr. Rita Valentino

The National Institute on Drug Abuse (NIDA) at the National Institutes of Health welcomed Dr. Rita Valentino today as the Director of the NIDA Division of Neuroscience and Behavior. Dr. Valentino’s career spans 26 years of academic, research, and leadership experience in pharmacology, psychiatry, and neurobiology. She previously directed the Stress Neurobiology Division within the Department of Anesthesiology at The Children’s Hospital of Philadelphia, and was a professor of anesthesiology and critical care at the University of Pennsylvania School of Medicine, Philadelphia.

Dr. Valentino is known for her research on the effects of social stress at different developmental stages, and the impact of coping style on behavioral and cognitive health, and how this can determine vulnerability to substance use. Her research in opioid neuropharmacology and neurobiological mechanisms has not only illuminated sex differences related to stress, but has also revealed links between stress and opioid systems that underlie co-morbidity between stress disorders, such as post-traumatic stress disorder and substance use.

"Dr. Valentino’s experience in brain research, electrophysiology, pharmacology and neurocircuitry of behavior will enable her to expand NIDA’s basic neuroscience program," said NIDA Director Nora D. Volkow. "She will also be able to take advantage of advances from the BRAIN Initiative while expanding collaborations within NIDA to advance translational opportunities for the prevention and treatment of substance use disorders."

"I am honored to be offered the position of Director of Neuroscience and Behavior at NIDA and thrilled to take it on. We are in a time when technological advances that ushered in the BRAIN Initiative can be directed towards elucidating the neurobiological underpinnings of the behaviors that define substance use," said Dr. Valentino. "I envision building research bridges between intramural and extramural research and between NIH institutes that share our scientific goals."

Dr. Valentino received her B.S. in pharmacy with highest distinction from the University of Rhode Island, Kingston, and her Ph.D. in Pharmacology from the University of Michigan, Ann Arbor. She completed her postdoctoral fellowship in neurobiology at the University of North Carolina, Chapel Hill, (1980-1981) and The Salk Institute, La Jolla, California (1981-1983). She has received academic appointments at some of the most prestigious research and education institutions in the United States, including George Washington University Medical School, Washington, D.C., and University of Pennsylvania.

Dr. Valentino fills the position left by Dr. Joni Rutter, who recently joined the NIH Office of the Director last year. Dr. Roger Little has been serving as the DNB Acting Director since February 2016.

"I want to express my full-hearted appreciation and gratitude to Dr. Little, who has played an important role in promoting internal collaborations and in expanding NIDA’s interactions with NIH institutes and initiatives," added Dr. Volkow.